Abstract
Atherosclerosis involves a specialized inflammatory process regulated by an intricate network of cytokine and chemokine signaling. Atherosclerotic lesions lead to the release of cytokines that can have multiple affects on various vascular cell functions either promoting lesion expansion or alternatively retard progression. Tumor necrosis factor-α (TNF-α) is one such cytokine that can activate both cell survival and cell death mechanisms simultaneously. Here we show that TNF-α induces apoptosis in human aortic endothelial cells (HAECs), while it promotes the proliferation of vascular smooth muscle cells (VSMCs). Both events involved the activation of the Rb–E2F1 transcriptional regulatory pathway. Stimulation of HAECs with TNF-α led to an increased expression of p73 protein and a reduction in the levels of p53. This involved apoptosis signal-regulating kinase 1 (ASK1)- mediated inactivation of Rb and its dissociation from the p73 promoter. In contrast, TNF-α stimulation of VSMCs enhanced the association of E2F1 with proliferative promoters like thymidylate synthase and cdc25A, while Rb was dissociated. ASK1 kinase has a critical role in the apoptotic process, as its depletion or dissociation from Rb reduced TNF-α-induced apoptosis. These results show that the cytokine TNF-α can elicit diametrically opposite responses in vascular endothelial cells and VSMCs, utilizing the Rb–E2F pathway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- AoSMC:
-
aortic smooth muscle cells
- ASK1:
-
apoptosis signal-regulating kinase 1
- EC:
-
endothelial cells
- HAEC:
-
human aortic endothelial cells
- TNF-α:
-
tumor necrosis factor-α
- VSMC:
-
vascular smooth muscle cells
References
Beg AA, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274: 782–784.
Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ . Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 1994; 23: 103–114.
Chen J, Fujii K, Zhang L, Roberts T, Fu H . Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci USA 2001; 98: 7783–7788.
Choy JC, Granville DJ, Hunt DW, McManus BM . Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001; 33: 1673–1690.
Madge LA, Pober JS . TNF signaling in vascular endothelial cells. Exp Mol Pathol 2001; 70: 317–325.
Ashkenazi A, Dixit VM . Death receptors: signaling and modulation. Science 1998; 281: 1305–1308.
Chen G, Goeddel DV . TNF-R1 signaling: a beautiful pathway. Science 2002; 296: 1634–1635.
Ichijo H . Molecular mechanisms for cell life and cell death. Kokubyo Gakkai Zasshi 1998; 65: 155–163.
Matsuzawa A, Ichijo H . Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. J Biochem (Tokyo) 2001; 130: 1–8.
Takeda K, Matsuzawa A, Nishitoh H, Ichijo H . Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 2003; 28: 23–29.
Dasgupta P, Betts V, Rastogi S, Joshi B, Morris M, Brennan B et al. Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery. J Biol Chem 2004; 279: 38762–38769.
Harbour JW, Dean DC . Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000; 2: E65–E67.
Liu DX, Nath N, Chellappan SP, Greene LA . Regulation of neuron survival and death by p130 and associated chromatin modifiers. Genes Dev 2005; 19: 719–732.
Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J et al. Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis. Mol Cell Biol 2004; 24: 9527–9541.
Harbour JW, Dean DC . The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000; 14: 2393–2409.
Phillips AC, Vousden KH . E2F-1 induced apoptosis. Apoptosis 2001; 6: 173–182.
Tonini T, Hillson C, Claudio PP . Interview with the retinoblastoma family members: do they help each other? J Cell Physiol 2002; 192: 138–150.
Kinkade R, Rizwani W, Chellappan S . E2F transcription factors in cell proliferation, apoptosis, senescence and cancer. In: Yoshida K (ed). Control of Cellular Physiology by Transcription Factors E2F. Research Signpost Press: Trivandrum, India, 2007.
Lopez-Marure R, Bernal AE, Zentella A . Interference with c-myc expression and RB phosphorylation during TNF-mediated growth arrest in human endothelial cells. Biochem Biophys Res Commun 1997; 236: 819–824.
Goukassian DA, Kishore R, Krasinski K, Dolan C, Luedemann C, Yoon YS et al. Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth. Circ Res 2003; 93: 162–169.
Kishore R, Luedemann C, Bord E, Goukassian D, Losordo DW . Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signal transduction pathways. Circ Res 2003; 93: 932–940.
Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115–126.
Tanaka H, Nishikawa O, Yukawa S, Yoshimoto M, Nishide I . Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients]. Nippon Jinzo Gakkai Shi 1999; 41: 1–7.
Wang Z, Rao PJ, Castresana MR, Newman WH . TNF-alpha induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype. Am J Physiol Heart Circ Physiol 2005; 288: H293–H301.
Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA et al. Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. Circ Res 1999; 84: 867–875.
Geng YJ, Azuma T, Tang JX, Hartwig JH, Muszynski M, Wu Q et al. Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur J Cell Biol 1998; 77: 294–302.
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275: 90–94.
Murray-Zmijewski F, Lane DP, Bourdon JC . p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 2006; 13: 962–972.
Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF . A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 2000; 407: 642–645.
Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol 2003; 5: 552–558.
Vallieres K, Petitclerc E, Laroche G . On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: an in vitro study. Vascul Pharmacol 2009; 51: 50–56.
Schwartz SM, Virmani R, Rosenfeld ME . The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2000; 2: 422–429.
Introna M, Mantovani A . Early activation signals in endothelial cells. Stimulation by cytokines. Arterioscler Thromb Vasc Biol 1997; 17: 423–428.
Chau BN, Chen TT, Wan YY, DeGregori J, Wang JY . Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation. Mol Cell Biol 2004; 24: 4438–4447.
Goetze S, Kintscher U, Kaneshiro K, Meehan WP, Collins A, Fleck E et al. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 2001; 159: 93–101.
Wang S, Nath N, Minden A, Chellappan S . Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. Embo J 1999; 18: 1559–1570.
Lau LM, Nugent JK, Zhao X, Irwin MS . HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 2008; 27: 997–1003.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
Horvilleur E, Bauer M, Goldschneider D, Mergui X, de la Motte A, Benard J et al. p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells. Nucleic Acids Res 2008; 36: 4222–4232.
Derossi D, Joliot AH, Chassaing G, Prochiantz A . The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994; 269: 10444–10450.
Acknowledgements
This study was supported by Grant no. CA63136 from the NCI to SPC. SR is a recipient of a post-doctoral award from the AHA (Grant no. 0425904B).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by V De Laurenzi
Rights and permissions
About this article
Cite this article
Rastogi, S., Rizwani, W., Joshi, B. et al. TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73. Cell Death Differ 19, 274–283 (2012). https://doi.org/10.1038/cdd.2011.93
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2011.93
Keywords
This article is cited by
-
Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
Basic Research in Cardiology (2021)
-
Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis
Cellular and Molecular Life Sciences (2019)
-
Analysis of Combined Transcriptomes Identifies Gene Modules that Differentially Respond to Pathogenic Stimulation of Vascular Smooth Muscle and Endothelial Cells
Scientific Reports (2018)
-
The next generation of therapeutics for chronic kidney disease
Nature Reviews Drug Discovery (2016)
-
A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression
Oncogene (2015)
